Ana Martínez-López

Tumor suppressor role of RBM22 in prostate cancer acting as a dual-factor regulating alternative splicing and transcription of key oncogenic genes.

E. Eyras, P. López-Casas, D. Olmos, 2022, Translational research : the journal of laboratory and clinical medicine.

From the Ronnett to the PSOGI Classification System for Pseudomyxoma Peritonei: A Validation Study

A. Romero-Ruiz, J. Briceño-Delgado, F. J. Medina-Fernández, 2021, Annals of Surgical Oncology.

Dysregulation of the splicing machinery is directly associated to aggressiveness of prostate cancer

Raúl M. Luque, E. Yubero-Serrano, R. Luque, 2020, EBioMedicine.

A Proposal for Modification of the PSOGI Classification According to the Ki-67 Proliferation Index in Pseudomyxoma Peritonei

M. Tena-Sempere, A. Romero-Ruiz, J. Castaño, 2021, Annals of Surgical Oncology.

Spliceosome Component SF3B1 as Novel Prognostic Biomarker and Therapeutic Target for Prostate Cancer.

R. Luque, J. Castaño, M. Gahete, 2019, Translational research : the journal of laboratory and clinical medicine.

Intraoperative oxygen tension and redox homeostasis in Pseudomyxoma peritonei: A short case series

A. Romero-Ruiz, C. Michán, J. Alhama, 2023, Frontiers in Oncology.